Troponin T-SS, as a conceptual component of the troponin complex, plays an integral role in the regulation of muscle contraction, particularly within the contexts of cardiac and skeletal muscle function. This protein, alongside troponin I and troponin C, forms a critical regulatory complex that controls the calcium-sensitive interactions between actin and myosin, the fundamental process behind muscle contractions. Troponin T's primary role within this complex is to bind to tropomyosin, effectively anchoring the troponin complex to the thin filament. This interaction is vital for the regulation of muscle contractions, as it allows for the precise control of actin's accessibility to myosin, thereby regulating the muscle's ability to contract. Inhibition of troponin T-SS, and by extension, the troponin complex, would directly impact the muscle contraction process, potentially leading to diminished muscle response or altered contractile function. The precise control exerted by troponin T is crucial for ensuring the efficiency and regulation of muscle contractions, highlighting its significance in muscle physiology and overall bodily function.
The inhibition of Troponin T-SS involves mechanisms that disrupt its normal function and interaction within the troponin complex and with tropomyosin. Such inhibition can occur through various pathways, including the alteration of its binding affinity to tropomyosin or interference with its ability to undergo conformational changes necessary for the regulation of muscle contraction. Molecular interference, such as the binding of specific inhibitors to troponin T-SS, could prevent the necessary conformational changes that facilitate the exposure of actin binding sites to myosin, thereby inhibiting muscle contraction. Additionally, post-translational modifications of troponin T-SS, such as phosphorylation or acetylation, may also modulate its function and interaction with other proteins in the complex, potentially leading to an inhibited state. These inhibitory processes are critical to understanding not just the function of troponin T-SS in muscle contractions but also the broader regulatory mechanisms that govern muscular responses and adaptations.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is another calcium channel blocker that can affect muscle contraction by modulating calcium levels within the cell. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is a selective inhibitor of non-muscle myosin II ATPase activity. It can indirectly affect TNNT1 by altering myosin activity. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 inhibits myosin light chain kinase, which could indirectly affect the activity of TNNT1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinase (ROCK), which could affect the regulation of muscle contraction. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $156.00 $612.00 | 27 | |
Calmidazolium chloride is a calmodulin antagonist that could influence the calcium-mediated regulation of muscle contraction. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of CaM kinase II (CaMKII), which could indirectly affect TNNT1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that can inhibit the sarcoplasmic reticulum Ca2+ ATPase, potentially affecting muscle contraction. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Cyclopiazonic acid is an inhibitor of the sarcoplasmic reticulum Ca2+-ATPase, which could indirectly affect TNNT1. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine alters the conductance of the ryanodine-sensitive calcium release channel in the sarcoplasmic reticulum, which can indirectly affect muscle contraction. | ||||||
Tetracaine | 94-24-6 | sc-255645 sc-255645A sc-255645B sc-255645C sc-255645D sc-255645E | 5 g 25 g 100 g 500 g 1 kg 5 kg | $66.00 $309.00 $500.00 $1000.00 $1503.00 $5000.00 | ||
Tetracaine is a local anesthetic that can block voltage-gated sodium channels, potentially affecting muscle contraction and thus TNNT1 indirectly. | ||||||